Getinge has received a warning letter from the US FDA concerning insufficient cleaning processes for its vascular grafts at its manufacturing facility in Wayne, New Jersey. The warning stems from an inspection carried out by the FDA earlier this year which highlighted two lapses in ...
Please Login to read the full article.
